First-ever vaccine to prevent RSV in older adults wins FDA approval ...Middle East

The Hill - News
First-ever vaccine to prevent RSV in older adults wins FDA approval
Federal regulators gave the green light to the first-ever vaccine to prevent the respiratory disease RSV on Wednesday, a major breakthrough that's been decades in the making. The Food and Drug Administration (FDA) approved Arexvy, a shot developed by pharmaceutical giant GlaxoSmithKline (GSK) to prevent lower respiratory tract disease caused by RSV in adults aged 60 and older. The development marks a significant turning point in the fight to protect vulnerable individuals against RSV, and other shots are close behind. A vaccine that was developed by Pfizer and aimed at the same demographic is expected to be approved by the end of the month. FDA is also considering Pfizer's ma

Hence then, the article about first ever vaccine to prevent rsv in older adults wins fda approval was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( First-ever vaccine to prevent RSV in older adults wins FDA approval )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News